GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 176 - 200 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 3 11 mild
G98068PA
3754
IgM Patient 2 3 mild
G49108TO
3745
IgG Patient 2 3 mild
G64669AQ
3726
IgA Patient 3 4 mild
G62222PE
3697
IgM Patient 1 6 moderate
G49108TO
3686
IgA Patient 3 -180 mild
G42346AP
3686
IgA Patient 2 24 mild
G15407YE
3676
IgA Patient 3 4 mild
G37383BH
3675
IgA Patient 3 11 mild
G08340FW
3668
IgG Patient 3 -180 mild
G68703KI
3666
IgA Patient 3 -180 mild
G98068PA
3647
IgA Patient 3 11 mild
G19118WX
3595
IgA Patient 3 4 mild
G69912LP
3593
IgG Patient 2 3 mild
G47362BJ
3585
IgA Patient 3 11 mild
G62222PE
3551
IgG Patient 2 24 mild
G42666HT
3507
IgA Patient 3 11 mild
G60761LT
3448
IgG Patient 3 -180 mild
G14569AR
3411
IgG Patient 2 3 mild
G62826CL
3408
IgM Patient 2 24 mild
G49108TO
3401
IgA Patient 3 -180 mild
G69912LP
3400
IgA Patient 3 -180 mild
G08340FW
3386
IgA Patient 3 4 mild
G99603GB
3373
IgM Patient 2 15 mild
G49108TO
3346
IgG Patient 3 4 mild
G96865DJ
3332

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024